Investigating how E-cadherin’s loss uniquely affects these tissues could provide insights crucial to advancing personalized screening and treatment for HLBC and HDGC. The gene discussed is CDH1; the disease is CDH1-related diffuse gastric and lobular breast cancer syndrome.